Egorov A - Search Results

1

IgGκ Signal Peptide Enhances the Efficacy of an Influenza Vector Vaccine against Respiratory Syncytial Virus Infection in Mice.

Pulkina A, Vasilyev K, Muzhikyan A, Sergeeva M, Romanovskaya-Romanko E, Shurygina AP, Shuklina M, Vasin A, Stukova M, Egorov A. Pulkina A, et al. Among authors: egorov a. Int J Mol Sci. 2023 Jul 14;24(14):11445. doi: 10.3390/ijms241411445. Int J Mol Sci. 2023. PMID: 37511205 Free PMC article.

2

Adaptive mutation in nuclear export protein allows stable transgene expression in a chimaeric influenza A virus vector.

Kuznetsova I, Shurygina AP, Wolf B, Wolschek M, Enzmann F, Sansyzbay A, Khairullin B, Sandybayev N, Stukova M, Kiselev O, Egorov A, Bergmann M. Kuznetsova I, et al. Among authors: egorov a. J Gen Virol. 2014 Feb;95(Pt 2):337-349. doi: 10.1099/vir.0.056036-0. Epub 2013 Nov 12. J Gen Virol. 2014. PMID: 24222196

3

A genetically adjuvanted influenza B virus vector increases immunogenicity and protective efficacy in mice.

Kittel C, Wressnigg N, Shurygina AP, Wolschek M, Stukova M, Romanovskaya-Romanko E, Romanova J, Kiselev O, Muster T, Egorov A. Kittel C, et al. Among authors: egorov a. Arch Virol. 2015 Oct;160(10):2525-34. doi: 10.1007/s00705-015-2525-9. Epub 2015 Jul 28. Arch Virol. 2015. PMID: 26215439

4

Interleukin-24 inhibits influenza A virus replication in vitro through induction of toll-like receptor 3 dependent apoptosis.

Weiss R, Laengle J, Sachet M, Shurygina AP, Kiselev O, Egorov A, Bergmann M. Weiss R, et al. Among authors: egorov a. Antiviral Res. 2015 Nov;123:93-104. doi: 10.1016/j.antiviral.2015.09.005. Epub 2015 Sep 11. Antiviral Res. 2015. PMID: 26367324

5

Intranasal Immunization with the Influenza A Virus Encoding Truncated NS1 Protein Protects Mice from Heterologous Challenge by Restraining the Inflammatory Response in the Lungs.

Vasilyev K, Shurygina AP, Sergeeva M, Stukova M, Egorov A. Vasilyev K, et al. Among authors: egorov a. Microorganisms. 2021 Mar 26;9(4):690. doi: 10.3390/microorganisms9040690. Microorganisms. 2021. PMID: 33810549 Free PMC article.

6

Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein.

Stukova MA, Sereinig S, Zabolotnyh NV, Ferko B, Kittel C, Romanova J, Vinogradova TI, Katinger H, Kiselev OI, Egorov A. Stukova MA, et al. Among authors: egorov a. Tuberculosis (Edinb). 2006 May-Jul;86(3-4):236-46. doi: 10.1016/j.tube.2006.01.010. Tuberculosis (Edinb). 2006. PMID: 16677861

7

Targeting an Oncolytic Influenza A Virus to Tumor Tissue by Elastase.

Kuznetsova I, Arnold T, Aschacher T, Schwager C, Hegedus B, Garay T, Stukova M, Pisareva M, Pleschka S, Bergmann M, Egorov A. Kuznetsova I, et al. Among authors: egorov a. Mol Ther Oncolytics. 2017 Sep 8;7:37-44. doi: 10.1016/j.omto.2017.09.002. eCollection 2017 Dec 15. Mol Ther Oncolytics. 2017. PMID: 29034314 Free PMC article.

8

The Potential of Influenza HA-Specific Immunity in Mitigating Lethality of Postinfluenza Pneumococcal Infections.

Klausberger M, Leneva IA, Falynskova IN, Vasiliev K, Poddubikov AV, Lindner C, Kartaschova NP, Svitich OA, Stukova M, Grabherr R, Egorov A. Klausberger M, et al. Among authors: egorov a. Vaccines (Basel). 2019 Nov 17;7(4):187. doi: 10.3390/vaccines7040187. Vaccines (Basel). 2019. PMID: 31744208 Free PMC article.

9

Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine.

Romanova J, Krenn BM, Wolschek M, Ferko B, Romanovskaja-Romanko E, Morokutti A, Shurygina AP, Nakowitsch S, Ruthsatz T, Kiefmann B, König U, Bergmann M, Sachet M, Balasingam S, Mann A, Oxford J, Slais M, Kiselev O, Muster T, Egorov A. Romanova J, et al. Among authors: egorov a. PLoS One. 2009 Jun 19;4(6):e5984. doi: 10.1371/journal.pone.0005984. PLoS One. 2009. PMID: 19543385 Free PMC article.

10

Live cold-adapted influenza A vaccine produced in Vero cell line.

Romanova J, Katinger D, Ferko B, Vcelar B, Sereinig S, Kuznetsov O, Stukova M, Erofeeva M, Kiselev O, Katinger H, Egorov A. Romanova J, et al. Among authors: egorov a. Virus Res. 2004 Jul;103(1-2):187-93. doi: 10.1016/j.virusres.2004.02.032. Virus Res. 2004. PMID: 15163508 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

792 results

Search Page